- Acquired by CannaVcell Sciences, Apr 2020
- Raised $5M PIPE, May 2024
- Raised $5.6M PIPE, Jan 2023
About
BioHarvest Sciences Inc. is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. The company develops science-based and clinically proven therapeutic solutions within two major business verticals: a contract development and manufacturing organization (CDMO) for customers seeking novel plant-based compounds, and a creator of proprietary nutraceutical health and wellness products, including dietary supplements. BioHarvest was founded in Israel in 2007 by Dr. Yochi Hagay and Dr. Zaki Rakib with a vision to marry science with nature to improve human health. Their first flagship product is VINIA®, a proprietary red grape cell product. The company has corporate offices in Vancouver, Canada, and its primary manufacturing and research campus is located in Yavneh, Israel.
Funding history · 7 rounds · $13.4M total
Headcount over time
Q&A
- What is BioHarvest's primary business and technology?
- BioHarvest is a biotechnology company that uses its patented Botanical Synthesis technology to produce plant-based compounds without growing the actual plant. They operate as a contract development and manufacturing organization (CDMO) and create proprietary nutraceutical health and wellness products.
- When was BioHarvest acquired and by whom?
- BioHarvest was acquired by CannaVcell Sciences in April 2020.
- What is BioHarvest's flagship product?
- BioHarvest's flagship product is VINIA®, a proprietary red grape cell product designed to provide the health benefits of red wine without the alcohol, sugars, or calories.
- What was the most recent funding event for BioHarvest?
- In June 2024, BioHarvest completed a PIPE funding round, raising $4,329,982.62.
- What is BioHarvest's employee count?
- BioHarvest has 11-50 employees.
- When did BioHarvest begin trading on the Nasdaq Global Market?
- BioHarvest Sciences began trading on the Nasdaq Global Market on November 12, 2024.
- What was BioHarvest's most recent public offering?
- In November 2025, BioHarvest had a Public Offering that raised $17,395,000.
- What clinical study did BioHarvest announce in February 2023?
- In February 2023, BioHarvest Sciences announced a clinical study in patients with multiple sclerosis-related optic neuritis.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | bioharvest.com/ |
|---|---|
| linkedin.com/company/35508843 | |
| facebook.com/BioHarvestSciences | |
| YouTube | youtube.com/channel/UCGRJWztmLoycsLFWqwXAzAw |
Identifiers & details
| Former names | Fruitura Bioscience |
|---|---|
| Founded | 2007 |
| Employees (exact) | 30 |
| Offices | Vancouver |
| Market cap | $117.6M |
| Status reason | Acquired by CannaVcell Sciences on Apr, 2020 |
Acquisitions & public offerings
Acquired by CannaVcell Sciences 2020-04
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | bioharvest.com |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513930370 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2007-01-24 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 4 — charge (1), annual_report (1), other (1), people (1) |
| Registered address | נחל שניר 9 יבנה |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-26 | רישום שעבוד |
| 2025-11-19 | דו~ח שנתי-עדכון כתובת |
| 2025-11-19 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-05-06 | עדכון בעלי תפקידים |